Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Campiglio M, Bufalino R, Sandri M, Ferri E, Aiello RA, De Matteis A, Mottolese M, De Placido S, Querzoli P, Jirillo A, Bottini A, Fantini M, Bonetti A, Pedani F, Mauri M, Molino A, Ferro A, Pupa SM, Sasso M, Ménard S, Balsari A, Tagliabue E

Open source

DOI: 10.1007/s10549-011-1484-4
Published: 2011 Jul
Container: Breast cancer research and treatment
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-011-1484-4,
  title = {Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.},
  author = {Campiglio M and Bufalino R and Sandri M and Ferri E and Aiello RA and De Matteis A and Mottolese M and De Placido S and Querzoli P and Jirillo A and Bottini A and Fantini M and Bonetti A and Pedani F and Mauri M and Molino A and Ferro A and Pupa SM and Sasso M and Ménard S and Balsari A and Tagliabue E},
  year = {2011},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-011-1484-4},
  url = {https://doi.org/10.1007/s10549-011-1484-4}
}

RIS

TY  - JOUR
TI  - Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.
AU  - Campiglio M
AU  - Bufalino R
AU  - Sandri M
AU  - Ferri E
AU  - Aiello RA
AU  - De Matteis A
AU  - Mottolese M
AU  - De Placido S
AU  - Querzoli P
AU  - Jirillo A
AU  - Bottini A
AU  - Fantini M
AU  - Bonetti A
AU  - Pedani F
AU  - Mauri M
AU  - Molino A
AU  - Ferro A
AU  - Pupa SM
AU  - Sasso M
AU  - Ménard S
AU  - Balsari A
AU  - Tagliabue E
PY  - 2011
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-011-1484-4
UR  - https://doi.org/10.1007/s10549-011-1484-4
ER  -

APA

M, C., R, B., M, S., E, F., RA, A., A, D. M., M, M., S, D. P., P, Q., A, J., A, B., M, F., A, B., F, P., M, M., A, M., A, F., SM, P., M, S., S, M., A, B., & E, T. (2011). Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-011-1484-4

Source records

pubmed · retrieved 2026-09-27T07:04:49.407Z